Method of choice for urinary diversion in surgical treatment of bladder carcinoma
β Scribed by N. A. Lopatkin; E. B. Mazo; O. K. Vartanyan
- Publisher
- Springer Netherlands
- Year
- 1976
- Tongue
- English
- Weight
- 626 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr
## BACKGROUND. Muscle-invasive urothelial carcinoma of the urinary bladder has a
therapeutic advantage over the cisplatin-based regimen M-VAC (methotrexate, Concepcio Β΄n Almanza, M.D. vinblastine, doxorubicin, and cisplatin) in the treatment of patients with surgically Begon Λa Bermejo, M.D. incurable advanced bladder carcinoma. Luis-Alfonso Sole Β΄, M.D. ## METHODS. Patients w